Nplate

Active Ingredient(s): Romiplostim
FDA Approved: * August 22, 2008
Pharm Company: * AMGEN
Category: Blood Clotting (Hemostasis)

Romiplostim, sold under the brand name Nplate among others, is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production. Contents 1 Indications and Marketing 2 Treatment regimen 3 Clinical efficacy 4 Side-effects 5 References 6 External links Indications and Marketing The drug was developed by Amgen through a restricted usage program called NEXUS.[1] During development and clinical trials the drug was called AMG531.[citation neede... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Nplate 250 ug/.5ml Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 55513-221
Labeler:
Amgen Inc
Nplate 500 ug/ml Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 55513-222
Labeler:
Amgen Inc
Nplate 125 mg/.25ml Subcutaneous Injection, Powder, Lyophilized, for Solution
NDC: 55513-223
Labeler:
Amgen Inc

Popular Topics

nplate

side effects...